Kezar Life Sciences, Inc. Contracts & Agreements
36 Contracts & Agreements
- Business Finance (9 contracts)
- Business Operations (1)
- Human Resources (18)
- Intellectual Property (2)
- Real Estate (2)
- Uncategorized (4)
- Advisor Agreement between the Company and Christopher Kirk, Ph.D., dated April 22, 2023 (Filed With SEC on August 10, 2023)
- Executive Employment Agreement between the Company and Nick Mordwinkin, Ph.D., dated July 11, 2022 (Filed With SEC on November 10, 2022)
- Forms of Stock Option Grant Notice and Option Agreement under the 2022 Inducement Plan (Filed With SEC on August 11, 2022)
- 2022 Inducement Plan (Filed With SEC on August 11, 2022)
- Loan and Security Agreement, dated as of November 4, 2021, by and between the Company and Oxford Finance LLC (Filed With SEC on March 17, 2022)
- Non-Employee Director Compensation Policy (Filed With SEC on March 17, 2022)
- Form of Restricted Stock Unit Grant Notice and Unit Award Agreement under 2018 Equity Incentive Plan (Filed With SEC on March 17, 2022)
- Sales Agreement dated as of November 19, 2021, between the Company and Cowen and Company, LLC (Filed With SEC on November 19, 2021)
- Non-Employee Director Compensation Plan (Filed With SEC on March 11, 2021)
- Underwriting Agreement, dated June 8, 2020, by and among the Company, Jefferies LLC, Cowen and Company, LLC and William Blair & Company L.L.C (Filed With SEC on June 10, 2020)
- Executive Employment Agreement, between the Company and Vassiliki Economides, dated January 14, 2020 (Filed With SEC on May 7, 2020)
- Executive Employment Agreement, between the Company and Noreen Henig, M.D., dated April 25, 2020 (Filed With SEC on May 7, 2020)
- Description of the Companys Securities (Filed With SEC on March 12, 2020)
- Amended and Restated Executive Employment Agreement between the Company and Marc L. Belsky, dated January 14, 2020 (Filed With SEC on March 12, 2020)
- Non-Employee Director Compensation Plan (Filed With SEC on March 12, 2020)
- Form of Pre-Funded Warrant (Filed With SEC on February 3, 2020)
- Underwriting Agreement, dated January 31, 2020, by and among the Company, Cowen and Company, LLC, Wells Fargo Securities, LLC and William Blair & Company L.L.C (Filed With SEC on February 3, 2020)
- Transition Services, Separation and General Release Agreement, between the Company and Niti Goel, M.D., dated August 6, 2019 (Filed With SEC on November 7, 2019)
- Amended and Restated Executive Employment Agreement between the Company and Niti Goel, dated June 8, 2018 (Filed With SEC on May 7, 2019)
- Confirmation of Lease Terms between the Company and AP3-SF1 4000 Shoreline, LLC, effective as of March 1, 2018 (Filed With SEC on March 26, 2019)
- Form of Common Stock Certificate of the Registrant (Filed With SEC on June 8, 2018)
- Exclusive License Agreement by and between the Registrant and Onyx Therapeutics, Inc., dated June 11, 2015 (Filed With SEC on June 8, 2018)
- Amended and Restated Executive Employment Agreement between the Registrant and Christopher J. Kirk, dated June 7, 2018 (Filed With SEC on June 8, 2018)
- Amended and Restated Executive Employment Agreement between the Registrant and John Fowler, dated June 7, 2018 (Filed With SEC on June 8, 2018)
- Form of Underwriting Agreement (Filed With SEC on June 8, 2018)
- Amended and Restated Investors Rights Agreement, by and among the Registrant and certain of its stockholders, dated June 26, 2017 (Filed With SEC on May 24, 2018)
- Form of Indemnity Agreement by and between the Registrant and its directors and officers (Filed With SEC on May 24, 2018)
- 2018 Equity Incentive Plan (Filed With SEC on May 24, 2018)
- Forms of Option Grant Notice and Option Agreement under 2018 Equity Incentive Plan (Filed With SEC on May 24, 2018)
- Form of Restricted Stock Unit Grant Notice and Unit Award Agreement under 2018 Equity Incentive Plan (Filed With SEC on May 24, 2018)
- 2015 Equity Incentive Plan, as amended (Filed With SEC on May 24, 2018)
- Form of Stock Option Agreement under the 2015 Equity Incentive Plan (Filed With SEC on May 24, 2018)
- Form of Stock Option AgreementEarly Exercise under the 2015 Equity Incentive Plan (Filed With SEC on May 24, 2018)
- 2018 Employee Stock Purchase Plan (Filed With SEC on May 24, 2018)
- Exclusive License Agreement by and between the Registrant and Onyx Therapeutics, Inc., dated June 11, 2015 (Filed With SEC on May 24, 2018)
- Lease between the Registrant and AP3-SF1 4000 Shoreline, LLC, dated August 16, 2017 (Filed With SEC on May 24, 2018)
